当前位置：
X-MOL 学术
›
Med. Chem.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Prospects for Discovering the Secondary Metabolites of Cordyceps Sensu Lato by the Integrated Strategy
Medicinal Chemistry ( IF 1.9 ) Pub Date : 2021-01-31 , DOI: 10.2174/1573406416666191227120425 Shabana Bibi 1 , Yuan-Bing Wang 1 , De-Xiang Tang 1 , Mohammad Amjad Kamal 2 , Hong Yu 1
更新日期：2020-12-30
Medicinal Chemistry ( IF 1.9 ) Pub Date : 2021-01-31 , DOI: 10.2174/1573406416666191227120425 Shabana Bibi 1 , Yuan-Bing Wang 1 , De-Xiang Tang 1 , Mohammad Amjad Kamal 2 , Hong Yu 1
Affiliation
Background: Some species of Cordyceps sensu lato are famous Chinese herbs with significant biological activities, often used as edible food and traditional medicine in China. Cordyceps represents the largest entomopathogenic group of fungi, including 40 genera and 1339 species in three families and incertae sedis of Hypocreales.
Objective: Most of the Cordyceps-derivatives have been approved clinically for the treatment of various diseases such as diabetes, cancers, inflammation, cardiovascular, renal and neurological disorders and are used worldwide as supplements and herbal drugs, but there is still need for highly efficient Cordyceps-derived drugs for fatal diseases with approval of the U.S. Food and Drug Administration.
京公网安备 11010802027423号